PubRank

Emanuele Angelucci

Author PubWeight™ 50.83‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Cardiovascular events and intensity of treatment in polycythemia vera. N Engl J Med 2012 5.87
2 ABVD versus modified stanford V versus MOPPEBVCAD with optional and limited radiotherapy in intermediate- and advanced-stage Hodgkin's lymphoma: final results of a multicenter randomized trial by the Intergruppo Italiano Linfomi. J Clin Oncol 2005 1.87
3 Chemotherapy-phased imatinib pulses improve long-term outcome of adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: Northern Italy Leukemia Group protocol 09/00. J Clin Oncol 2010 1.77
4 Outcome of patients with hemoglobinopathies given either cord blood or bone marrow transplantation from an HLA-identical sibling. Blood 2013 1.68
5 New approach for bone marrow transplantation in patients with class 3 thalassemia aged younger than 17 years. Blood 2004 1.51
6 Reproducibility of liver iron concentration measured on a biopsy sample: a validation study in vivo. Am J Hematol 2014 1.44
7 Iron overload and iron chelation therapy in patients with myelodysplastic syndrome treated by allogeneic stem-cell transplantation: report from the working conference on iron chelation of the Gruppo Italiano Trapianto di Midollo Osseo. Am J Hematol 2011 1.42
8 Dexamethasone plus rituximab yields higher sustained response rates than dexamethasone monotherapy in adults with primary immune thrombocytopenia. Blood 2010 1.34
9 Prognostic impact of pre-transplantation transfusion history and secondary iron overload in patients with myelodysplastic syndrome undergoing allogeneic stem cell transplantation: a GITMO study. Haematologica 2009 1.28
10 Valproic acid at therapeutic plasma levels may increase 5-azacytidine efficacy in higher risk myelodysplastic syndromes. Clin Cancer Res 2009 1.21
11 Myocardial iron overload assessment by T2* magnetic resonance imaging in adult transfusion dependent patients with acquired anemias. Haematologica 2008 1.19
12 Predictive factors for the outcome of allogeneic transplantation in patients with MDS stratified according to the revised IPSS-R. Blood 2014 1.19
13 Management of chronic viral hepatitis in patients with thalassemia: recommendations from an international panel. Blood 2010 1.17
14 Dose-dense and high-dose chemotherapy plus rituximab with autologous stem cell transplantation for primary treatment of diffuse large B-cell lymphoma with a poor prognosis: a phase II multicenter study. Haematologica 2009 1.15
15 High cure rates in Burkitt lymphoma and leukemia: a Northern Italy Leukemia Group study of the German short intensive rituximab-chemotherapy program. Haematologica 2013 1.12
16 Hematopoietic stem cell transplantation for paroxysmal nocturnal hemoglobinuria: long-term results of a retrospective study on behalf of the Gruppo Italiano Trapianto Midollo Osseo (GITMO). Haematologica 2009 1.10
17 Correction of anemia in a transfusion-dependent patient with primary myelofibrosis receiving iron chelation therapy with deferasirox (Exjade, ICL670). Eur J Haematol 2007 1.07
18 Reversibility of cirrhosis in patients cured of thalassemia by bone marrow transplantation. Ann Intern Med 2002 1.06
19 CD20 expression has no prognostic role in Philadelphia-negative B-precursor acute lymphoblastic leukemia: new insights from the molecular study of minimal residual disease. Haematologica 2011 1.05
20 Hepatitis B virus-related liver disease in isolated anti-hepatitis B-core positive lymphoma patients receiving chemo- or chemo-immune therapy. Haematologica 2008 1.04
21 New strategies in the treatment of the thalassemias. Annu Rev Med 2005 1.03
22 Clearance of minimal residual disease after allogeneic stem cell transplantation and the prediction of the clinical outcome of adult patients with high-risk acute lymphoblastic leukemia. Haematologica 2007 0.99
23 Allogeneic stem cell transplantation for thalassemia major. Haematologica 2008 0.95
24 Risk of malignant lymphoma following viral hepatitis infection. Int J Hematol 2008 0.94
25 Anemia in beta-thalassemia patients targets hepatic hepcidin transcript levels independently of iron metabolism genes controlling hepcidin expression. Haematologica 2008 0.93
26 HIF-1α of bone marrow endothelial cells implies relapse and drug resistance in patients with multiple myeloma and may act as a therapeutic target. Clin Cancer Res 2013 0.87
27 Glucose-6-phosphate dehydrogenase polymorphism and lymphoma risk. Tumori 2007 0.85
28 High dose sequential chemotherapy with autologous transplantation versus dose-dense chemotherapy MegaCEOP as first line treatment in poor-prognosis diffuse large cell lymphoma: an "Intergruppo Italiano Linfomi" randomized trial. Haematologica 2005 0.85
29 Prevalence, severity and correlates of fatigue in newly diagnosed patients with myelodysplastic syndromes. Br J Haematol 2014 0.84
30 Interleukin-1B (IL1B) and interleukin-6 (IL6) gene polymorphisms are associated with risk of chronic lymphocytic leukaemia. Hematol Oncol 2008 0.84
31 Pentraxin 3 (PTX3) inhibits plasma cell/stromal cell cross-talk in the bone marrow of multiple myeloma patients. J Pathol 2012 0.84
32 Patient- versus physician-reporting of symptoms and health status in chronic myeloid leukemia. Haematologica 2013 0.82
33 The role of oxidant injury in the pathophysiology of human thalassemias. Redox Rep 2003 0.82
34 Optimal timing of allogeneic hematopoietic stem cell transplantation in patients with myelodysplastic syndrome. Am J Hematol 2013 0.81
35 Primary non-Hodgkin's lymphoma of the breast: a report of 11 cases. Haematologica 2004 0.81
36 Unexpected CNS localization in M2 acute myeloid leukemia: a link with past heroin addiction? Am J Hematol 2008 0.80
37 Clinical management of gastrointestinal disturbances in patients with myelodysplastic syndromes receiving iron chelation treatment with deferasirox. Leuk Res 2011 0.80
38 Household contact with pets and birds and risk of lymphoma. Cancer Causes Control 2010 0.80
39 Treatment of hepatitis C in patients with thalassemia. Haematologica 2008 0.80
40 The evolving clinical scenario of myelodysplastic syndrome: the need for a complete and up to date upfront diagnostic assessment. Eur J Intern Med 2010 0.78
41 Cytarabine and clofarabine after high-dose cytarabine in relapsed or refractory AML patients. Am J Hematol 2012 0.78
42 Treosulfan/fludarabine as an allogeneic hematopoietic stem cell transplant conditioning regimen for high-risk patients. Am J Hematol 2008 0.77
43 Correlation between eight-gene expression profiling and response to therapy of newly diagnosed multiple myeloma patients treated with thalidomide-dexamethasone incorporated into double autologous transplantation. Ann Hematol 2013 0.76
44 Another Step Forward in Iron Chelation Therapy. Acta Haematol 2015 0.76
45 Reduced Left Ventricular Contractile Reserve Identified by Low Dose Dobutamine Echocardiography as an Early Marker of Cardiac Involvement in Asymptomatic Patients with Thalassemia Major. Echocardiography 1996 0.76
46 Patterns of iron distribution in liver cells in beta-thalassemia studied by X-ray microanalysis. Haematologica 2002 0.75
47 High prevalence of non-HFE gene-associated haemochromatosis in patients from southern Italy. Clin Chem Lab Med 2004 0.75
48 Iron overload, cardiac iron loading and function in myelodysplastic syndrome. Leuk Res 2009 0.75
49 Do matrix metalloproteinase-1 and glucose-6-phosphate dehydrogenase gene polymorphisms interact in promoting lymphoma development? Leuk Lymphoma 2013 0.75
50 Cardiogenic Shock during First Infusion of Anthracycline Chemotherapy in a Patient with Hodgkin Lymphoma: An Unusual Event. Cardiology 2017 0.75
51 Long term outcome of localized aggressive non-Hodgkin lymphoma treated with a short weekly chemotherapy regimen (doxorubicin, cyclophosphamide, bleomycin, vincristine, and prednisone) and involved field radiotherapy: result of a Gruppo Italiano Multiregionale per lo Studio dei Linfomi e Leucenie (GIMURELL) study. Leuk Lymphoma 2009 0.75
52 Quality of life in elderly patients with essential thrombocythaemia. An Italian multicentre study. Ann Hematol 2011 0.75
53 Sudden cardiac failure in a beta-thalassemia major patient receiving chemotherapy for acute promyelocytic leukemia. Leuk Lymphoma 2007 0.75
54 Marginal zone B-cell lymphoma arising in donor cells in a Hepatitis-C virus infected patient over 20 years after allogeneic bone marrow transplantation. Leuk Lymphoma 2008 0.75